6 Ways to Discover Greater Value from Your Safety Platform
Learn how new advancements in artificial intelligence (AI) and generative AI (GenAI) are transforming Agency queries and information exchanges.
Felix Arellano
Global Head of Drug Safety – Roche
Hans van Leeuwen
Global Head of Regulatory Operations – Astellas
Julie Thomas
Vice President, Global Medical Safety Operations – Johnson & Johnson
Learn how new advancements in artificial intelligence (AI) and generative AI (GenAI) are transforming Agency queries and information exchanges.
Learn how new advancements in artificial intelligence (AI) and generative AI (GenAI) are transforming Agency queries and information exchanges.
Learn how new advancements in artificial intelligence (AI) and generative AI (GenAI) are transforming Agency queries and information exchanges.
Sam Wallis, Head of ICSR Case Processing within the Worldwide Patient Safety Operations at Bristol Myers Squibb, will join a Breakthrough 2024 panel discussion on the reality of transitioning Safety/Regulatory systems to the cloud. Here, he provides a glimpse into BMS’s own journey, which he’ll share candidly during the Day 1 debate.
At Breakthrough 2024 this month, Hans van Leeuwen, Head of RA Data and Systems Excellence at Astellas Pharma, will deliver a keynote on the company’s journey to the cloud for regulatory information management.
ArisGlobal’s annual Breakthrough is a one-of-a-kind event bringing together industry ...
Learn how exciting new technological innovations are set to impact how regulatory information management teams work in 2024 and beyond.
Learn how exciting new technological innovations are set to impact how regulatory information management teams work in 2024 and beyond.
Safety is evolving rapidly. There is a major, emerging opportunity ...
Nothing evolves within a vacuum. While today we can transmit ...
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 500 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved